InterventionsHuman trial

Safety, Tolerability, PK, and PD of Elecoglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Chinese Adults Living with Obesity or Overweight With or Without Type 2 Diabetes

ADA Scientific Sessions 2026 Abstract

The paper

Chengdu

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2844-LB

doi.org/10.2337/db26-2844-lb